» Authors » Linghong Guo

Linghong Guo

Explore the profile of Linghong Guo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 60
Citations 583
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Wang L, Zhu Y, Zhang L, Guo L, Wang X, Pan Z, et al.
Cell Death Dis . 2023 Dec; 14(12):851. PMID: 38129399
Pyroptosis, apoptosis, and necroptosis are mainly programmed cell death (PCD) pathways for host defense and homeostasis. PANoptosis is a newly distinct inflammatory PCD pathway that is uniquely regulated by multifaceted...
12.
Wu S, Xu Y, Yang L, Guo L, Jiang X
Front Immunol . 2023 Dec; 14:1294416. PMID: 38106423
Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42022363127.
13.
Wu S, Xu Y, Guo L, Jiang X
Int Wound J . 2023 Nov; 21(3):e14487. PMID: 37973553
A meta-analysis research was implemented to appraise the effect of antibiotic bone cement (ABC) in treating infected diabetic foot wounds (IDFWs). Inclusive literature research till April 2023 was done and...
14.
Xu Y, Guo L, Wu S, Zhang T, Jiang X
Br J Dermatol . 2023 Oct; 191(2):290-292. PMID: 37793178
No abstract available.
15.
Xu Y, Guo L, Li Z, Wu S, Jiang X
Pediatr Dermatol . 2023 Aug; 40(5):841-850. PMID: 37529963
Background: Dupilumab is the first biologic approved for the treatment of moderate-to-severe atopic dermatitis (AD) in children and adolescents. Previous systematic reviews explored the effectiveness and safety of dupilumab in...
16.
Guo L, Yang Y, Pu Y, Mao S, Nie Y, Liu Y, et al.
J Ethnopharmacol . 2023 Jul; 318(Pt B):116974. PMID: 37517571
Ethnopharmacological Relevance: Dendrobium officinale Kimura & Migo is traditionally used to treat skin diseases, gastrointestinal diseases, and other diseases. Dendrobium officinale polysaccharides (DOP) are the main component of Dendrobium officinale...
17.
Xu Y, Guo L, Li Z, Wu S, Jiang X
Int J Dermatol . 2023 Jul; 62(11):e601-e604. PMID: 37424362
No abstract available.
18.
Xu Y, Li Z, Wu S, Guo L, Jiang X
Front Immunol . 2023 Jun; 14:1180170. PMID: 37334353
Background: Orally administered small-molecule drugs including tyrosine kinase 2 (TYK2) inhibitors and phosphodiesterase 4 (PDE4) inhibitors are new candidates for systemic therapy in plaque psoriasis. However, no previous articles evaluated...
19.
Mao S, Guo L, Li P, Shen K, Jiang M, Liu Y
Adv Physiol Educ . 2023 Mar; 47(2):272-281. PMID: 36927057
COVID-19 struck the world suddenly and unexpectedly. Since traditional education requires face-to-face communication, to avoid further spreading of the virus a majority part of that education has moved online. Our...
20.
Li R, Yuan X, Zhang L, Jiang X, Li L, Zhang Y, et al.
Mol Biomed . 2023 Jan; 4(1):1. PMID: 36602633
Hair loss is a common skin disease that causes intense emotional suffering. Hair regeneration in a personalized area is highly desirable for patients with different balding conditions. However, the existing...